Enzyme is expected to be used as a therapeutic agent because of its unique specificity and high level of activity. However, due to many shortcomings, clinically important enzyme drugs are not as common as conventional low molecular weight drugs. The most important of these are poor stability, potential immunogenicity and potential systemic toxicity. The latest progress in the synthesis and characterization of nanoparticles and the exciting novel properties of some types of nanomaterials have aroused interest in the use of nanoparticles as enzyme drug carriers. In some cases, the use of enzymes attached to nanoparticles can help overcome some of these problems and improve the clinical application prospects of enzyme drugs. Enzyme Labeling Nanoparticle services https://bioconjugation.bocsci.com/services/enzyme-labeling-of-nanoparticle.html